Durham, NCNCT07811362Now EnrollingIRB Ready

Complex Regional Pain Syndrome I (CRPS I) Clinical Trial in Durham, NC

Access cutting-edge complex regional pain syndrome i (crps i) treatment through this clinical trial at a research site in Durham. Study-provided care at no cost to qualified participants.

Sponsored by Ambros Therapeutics, Inc.

Quick Self-Assessment

See if you qualify for this Durham location

Preparing your pre-screening questions…

Expert Care in Durham

Access complex regional pain syndrome i (crps i) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related complex regional pain syndrome i (crps i) treatment provided free

Apply for This Durham Location

Check if you qualify for this complex regional pain syndrome i (crps i) clinical trial in Durham, NC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Durham

    Convenient for NC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Durham site if eligible
  4. 4Begin participation

About This Complex Regional Pain Syndrome I (CRPS I) Study in Durham

The goal of this observational study is to learn about how well neridronate keeps working in the months after treatment. For 12 or up to 24 months while the registry is open participants will answer online survey questions about their CRPS pain, medication use or procedures done and how CRPS affects what they are able to do.

Sponsor: Ambros Therapeutics, Inc.

Who Can Participate

Inclusion Criteria

Participants from CRPS-RISE
Completion of four infusions of IP (neridronate 100 mg over a \~ 10-day period \[or the renally modified dosing, as applicable\] or placebo) in CRPS-RISE .
Completed CRPS-RISE with a final trial visit at Week 6 (Visit 8) or later. Participants who meet both criteria will be provisionally enrolled pending post-trial unblinding and be included in the Provisionally Enrolled Study Cohort. After CRPS-RISE last patient last visit unblinding, only participants who meet the following neridronate exposure criterion #3 will continue in registry follow-up and be included in the Enrolled Study Cohort:
Completion of 4-infusions of neridronate 100 mg over approximately a 10-day period in CRPS-RISE.
Participants from the Open Label Extension (OLE)
Completion of 4 infusions of neridronate 100 mg over approximately a 10-day period (or the renally modified dosing, as applicable) in the OLE.
Completed OLE with a final trial visit at Week 6 (Visit 8) or later.

Exclusion Criteria

There are no exclusion criteria.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Durham?

Yes, this clinical trial (NCT07811362) has an active research site in Durham, NC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Complex Regional Pain Syndrome I (CRPS I) Treatment Options in Durham, NC

If you're searching for complex regional pain syndrome i (crps i) treatment options in Durham, NC, this clinical trial (NCT07811362) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Durham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced complex regional pain syndrome i (crps i) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all complex regional pain syndrome i (crps i) clinical trials near you to find additional studies recruiting in your area.

More Chronic Pain Trials in Durham, NC

See all chronic pain clinical trials recruiting in Durham — not just this study.

Browse Chronic Pain Trials in Durham →

Ready to Join in Durham?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Durham, NC